Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma

MLA

Bingran Wang, et al. “Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.” Frontiers in Immunology, vol. 13, May 2022. EBSCOhost, https://doi.org/10.3389/fimmu.2022.902060.

APA

Bingran Wang, Yizheng Xue, & Wei Zhai. (2022). Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma. Frontiers in Immunology, 13. https://doi.org/10.3389/fimmu.2022.902060

Chicago

Bingran Wang, Yizheng Xue, and Wei Zhai. 2022. “Integration of Tumor Microenvironment in Patient-Derived Organoid Models Help Define Precision Medicine of Renal Cell Carcinoma.” Frontiers in Immunology 13 (May). doi:10.3389/fimmu.2022.902060.